Cellcraft

Cellcraft develops Cellcraft IQ, an AI-native bioprocess automation and optimisation software that the company describes as a plug-and-play operating system for bioreactors. It can run in an advisory mode that surfaces recommendations to operators or in a full automation mode, and the company says it integrates via standard industrial protocols in under 12 weeks. The company has filed a patent for its Ensemble AI architecture, which combines machine learning, physics-constrained modelling and adaptive control.

The company targets bio-manufacturing, including biopharma and vaccines, fermentation, cell therapies and cultivated meat. The website addresses investors, production partners and suppliers, and does not describe pricing or a specific revenue model.

Cellcraft was founded at the University of Cambridge by Yash Mishra and Clarisse Beurrier. The registered office is in London and the website lists Cambridge and London as locations. The company has one open role listed, titled "Open Application", based in Cambridge.

Product: Cellcraft IQ, an AI plug-and-play operating system for bioreactor automation and optimisation.